, Hong Kong

Avo Insurance pilots protection plan for mainland China travellers

It will offer COVID-19 real-time PCR tests and extra benefits.

Hong Kong digital insurer Avo Insurance has launched a new travel protection plan for travellers returning to mainland China, according to an announcement.

In partnership with the Chinese University of Hong Kong (CUHK) Medical Clinic, Avo Insurance will offer COVID-19 real-time PCR tests to its clients. In addition, policyholders are eligible to extra benefits to their China Travel Protection or Greater Bay Area Travel Protection, which have premiums starting at $1 (HK$8) and $5 (HK$36) respectively.

Policyholders of GBA Travel Protection or China Travel Protections are eligible to extend their protection with COVID-19 testing by CU Clinic and coronavirus disease protection for a total of $123 (HK$950).

They will be required to arrange an appointment with CU Clinic for a deep throat saliva test before departure. After one to two working days from the specimen submission date, the test report will be delivered by a local testing institution recognised by the government. In the event of a positive diagnosis, policyholders can redeem hospital cash of $1,300 (HK$10,000) during the 30-day coverage period of coronavirus disease protection, starting from the departure date.

Prudential, StanChart memperkuat 25 Tahun kemitraan bancassurance

Mereka memiliki kemitraan bancassurance terlama di Singapura dan Asia.

MSIG Asia dan RiskPoint mempertaruhkan asuransi energi terbarukan

Kawasan Asia-Pasifik berpotensi menarik investasi sebesar $3 triliun dalam pembangkitan listrik hingga 2033.

Kantor pusat Pru Life UK di Manila menerapkan kerja hibrida

Kantor ini memiliki area rekreasi dan kesehatan untuk membantu karyawan menyegarkan diri.

Etiqa meluncurkan produk asuransi takaful pertama di Singapura

Permintaan terhadap produk keuangan Islam dari Timur Tengah dan Asia Tenggara terus meningkat.

Perusahaan asuransi jiwa Singapura bidik pertumbuhan di 2025

Dorongan untuk solusi layanan kesehatan inovatif di tengah inflasi medis menjadi tantangan.